Login

Hantz Group employs a holistic approach to provide clients with comprehensive financial, estate, and tax planning solutions. 00:10:00

Share On Facebook Share On Twitter

John Hantz - Chief Executive Officer - Hantz Holdings llc

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Capstone Capital: Building Long-Term Relationships with Conservative Financial Strategies
00:10:00
Interview with Ed Clarke, CEO of Yojee Ltd | Ed Clarke, CEO, Yojee LtdYOJ:ASX
00:10:00
Navigating High-Yield Dynamics and Market Insights | Mark Attanasio, Co-Founder, Crescent Capital Group.
00:10:00
Quick Guide: How to Perform a Compliance Test on the Air XS Silica Monitor
00:10:00
PrecisionOptics demonstrates Taiwan’s strong industrial strength|CEO,Apogee Optocom Co Ltd
00:10:00
Investor Jenny Harrington is buying shares of Clearway Energy due to favorable valuation and growth prospects at current levels.
00:10:00
Online viralgen new facilities sub-eng sin band 1 | Gustavo Pesquin, CEO, ASKLEPIOS BIOPHARMACEUTICAL, INC.
00:10:00
How a Chance Encounter with Robert Kiyosaki’s Book Changed My Life
00:10:00
John Doerr Discusses 'Measure What Matters' and the Future of Tech and Healthcare | John Doerr, Chairman,  Kleiner Perkins.
00:10:00
Joseph Simonian, Senior Investment Strategist at Acadian Asset Management, speaks in collaboration with RavenPack.
00:10:00
Florencia Stefani Explores Savings, Inflation, Economic Slowdown, and Pension Reform with Economist Michèle Labbé | LarrainVial Asset Management
00:10:00
Telecom Italia CEO Pietro Labriola discusses the company's financial results with CNBC.

© 2017 - Neuhu+